Japan · Delayed Price · Currency is JPY Riken Vitamin Statistics
Total Valuation
Riken Vitamin has a market cap or net worth of JPY 84.13 billion. The enterprise value is 71.79 billion.
| Market Cap | 84.13B |
| Enterprise Value | 71.79B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Sep 29, 2025 |
Share Statistics
Riken Vitamin has 29.80 million shares outstanding. The number of shares has decreased by -7.17% in one year.
| Current Share Class | 29.80M |
| Shares Outstanding | 29.80M |
| Shares Change (YoY) | -7.17% |
| Shares Change (QoQ) | -1.07% |
| Owned by Insiders (%) | 11.09% |
| Owned by Institutions (%) | 26.96% |
| Float | 21.95M |
Valuation Ratios
The trailing PE ratio is 9.10.
| PE Ratio | 9.10 |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| PB Ratio | 1.06 |
| P/TBV Ratio | 1.08 |
| P/FCF Ratio | 26.18 |
| P/OCF Ratio | 10.66 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.02, with an EV/FCF ratio of 22.34.
| EV / Earnings | 7.65 |
| EV / Sales | 0.75 |
| EV / EBITDA | 6.02 |
| EV / EBIT | 8.23 |
| EV / FCF | 22.34 |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.13.
| Current Ratio | 3.11 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | 3.08 |
| Interest Coverage | 70.93 |
Financial Efficiency
Return on equity (ROE) is 12.05% and return on invested capital (ROIC) is 6.00%.
| Return on Equity (ROE) | 12.05% |
| Return on Assets (ROA) | 4.71% |
| Return on Invested Capital (ROIC) | 6.00% |
| Return on Capital Employed (ROCE) | 9.50% |
| Revenue Per Employee | 51.44M |
| Profits Per Employee | 5.05M |
| Employee Count | 1,858 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.37 |
Taxes
In the past 12 months, Riken Vitamin has paid 3.31 billion in taxes.
| Income Tax | 3.31B |
| Effective Tax Rate | 26.08% |
Stock Price Statistics
The stock price has increased by +0.89% in the last 52 weeks. The beta is -0.11, so Riken Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | -0.11 |
| 52-Week Price Change | +0.89% |
| 50-Day Moving Average | 2,655.46 |
| 200-Day Moving Average | 2,523.30 |
| Relative Strength Index (RSI) | 70.93 |
| Average Volume (20 Days) | 45,585 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Riken Vitamin had revenue of JPY 95.58 billion and earned 9.39 billion in profits. Earnings per share was 310.06.
| Revenue | 95.58B |
| Gross Profit | 31.27B |
| Operating Income | 8.73B |
| Pretax Income | 12.71B |
| Net Income | 9.39B |
| EBITDA | 11.93B |
| EBIT | 8.73B |
| Earnings Per Share (EPS) | 310.06 |
Balance Sheet
The company has 22.30 billion in cash and 9.91 billion in debt, giving a net cash position of 12.38 billion or 415.52 per share.
| Cash & Cash Equivalents | 22.30B |
| Total Debt | 9.91B |
| Net Cash | 12.38B |
| Net Cash Per Share | 415.52 |
| Equity (Book Value) | 79.20B |
| Book Value Per Share | 2,649.91 |
| Working Capital | 44.57B |
Cash Flow
In the last 12 months, operating cash flow was 7.89 billion and capital expenditures -4.68 billion, giving a free cash flow of 3.21 billion.
| Operating Cash Flow | 7.89B |
| Capital Expenditures | -4.68B |
| Free Cash Flow | 3.21B |
| FCF Per Share | 107.84 |
Margins
Gross margin is 32.72%, with operating and profit margins of 9.13% and 9.82%.
| Gross Margin | 32.72% |
| Operating Margin | 9.13% |
| Pretax Margin | 13.29% |
| Profit Margin | 9.82% |
| EBITDA Margin | 12.48% |
| EBIT Margin | 9.13% |
| FCF Margin | 3.36% |
Dividends & Yields
This stock pays an annual dividend of 110.00, which amounts to a dividend yield of 3.94%.
| Dividend Per Share | 110.00 |
| Dividend Yield | 3.94% |
| Dividend Growth (YoY) | 19.23% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 29.57% |
| Buyback Yield | 7.17% |
| Shareholder Yield | 11.19% |
| Earnings Yield | 11.16% |
| FCF Yield | 3.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Riken Vitamin has an Altman Z-Score of 3.76 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.76 |
| Piotroski F-Score | 6 |